View of Synthesis and Characterization of Pullulan Encapsulated Ursolic Acid Nanoparticles for Enhanced Bioavailability and Acetylcholinesterase Inhibition in Alzheimer’s Disease Therapy

Return to Article Details Synthesis and Characterization of Pullulan Encapsulated Ursolic Acid Nanoparticles for Enhanced Bioavailability and Acetylcholinesterase Inhibition in Alzheimer’s Disease Therapy Download Download PDF